Cancer-induced spiculation on computed tomography: a significant preoperative prognostic factor for colorectal cancer.


Journal

Surgery today
ISSN: 1436-2813
Titre abrégé: Surg Today
Pays: Japan
ID NLM: 9204360

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 29 12 2018
accepted: 20 01 2019
pubmed: 23 2 2019
medline: 18 12 2019
entrez: 22 2 2019
Statut: ppublish

Résumé

Cancer-induced spiculation (CIS) on computed tomography, which is reticular or linear opacification of the pericolorectal fat tissues around the cancer site, is generally regarded as cancer infiltration into T3 or T4, but its clinicopathological significance is unknown. This study examines the correlation between CIS and clinicopathological findings to establish its prognostic value. The subjects of this retrospective study were 335 patients with colorectal cancer (CRC), who underwent curative surgery between January, 2010 and December, 2011, at the National Defense Medical College Hospital in Saitama Prefecture, Japan. The level of interobserver agreement in the evaluation of CIS was substantial (83%; kappa value, 0.65). The presence of CIS was specific for T3/T4 disease (positive predictive value, 88.3%), and was significantly associated with tumor size and venous invasion. The 5-year relapse-free survival rate was significantly lower in patients with CIS than in those without CIS (68.6% and 84.0%, respectively, p = 0.001). Subgroup analysis revealed remarkable prognostic differences in patients with stage III and T3 disease. Multivariate analysis revealed that CIS was a significant independent prognostic factor. CIS was a significant preoperative prognostic factor and could be useful in the selection of preoperative therapy for patients with CRC.

Identifiants

pubmed: 30790053
doi: 10.1007/s00595-019-01780-2
pii: 10.1007/s00595-019-01780-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

629-636

Références

N Engl J Med. 2001 Aug 30;345(9):638-46
pubmed: 11547717
Lancet. 2002 May 18;359(9319):1727-33
pubmed: 12049861
World J Surg. 2004 Mar;28(3):263-70
pubmed: 14961200
Nature. 2004 Nov 18;432(7015):332-7
pubmed: 15549095
N Engl J Med. 2006 Jul 6;355(1):11-20
pubmed: 16822992
Br J Cancer. 2007 Apr 10;96(7):1030-6
pubmed: 17353925
Dis Colon Rectum. 2008 Jun;51(6):875-81
pubmed: 18350337
Surg Today. 2008;38(7):597-602
pubmed: 18612783
Lancet. 2009 Mar 7;373(9666):811-20
pubmed: 19269519
Semin Cell Dev Biol. 2010 Feb;21(1):19-25
pubmed: 19857592
Exp Cell Res. 2010 May 1;316(8):1324-31
pubmed: 20211171
Br J Cancer. 2010 May 11;102(10):1519-23
pubmed: 20407439
Cancer Cell. 2012 Mar 20;21(3):309-22
pubmed: 22439926
Int J Colorectal Dis. 2012 Oct;27(10):1347-57
pubmed: 22460305
Lancet Oncol. 2012 Nov;13(11):1152-60
pubmed: 23017669
Front Oncol. 2014 Mar 27;4:62
pubmed: 24734219
Medicine (Baltimore). 2014 Dec;93(28):e231
pubmed: 25526442
Nat Genet. 2015 Apr;47(4):312-9
pubmed: 25706627
Nat Genet. 2015 Apr;47(4):320-9
pubmed: 25706628
J Cancer Res Clin Oncol. 2017 Jul;143(7):1235-1242
pubmed: 28243747
AJR Am J Roentgenol. 1988 Feb;150(2):301-6
pubmed: 3257314
Br J Surg. 1988 Jul;75(7):641-4
pubmed: 3416116
AJR Am J Roentgenol. 1986 Apr;146(4):703-10
pubmed: 3485343
Radiology. 1986 Feb;158(2):347-53
pubmed: 3941861
Radiology. 1994 Mar;190(3):715-20
pubmed: 8115617
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571

Auteurs

Tadakazu Ao (T)

Department of Surgery, National Defense Medical College, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.

Yoshiki Kajiwara (Y)

Department of Surgery, National Defense Medical College, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan. ykaji@ndmc.ac.jp.

Kentaro Yamada (K)

Dotter Interventional Institute, Oregon Health and Science University, Portland, OR, 97239, USA.

Eiji Shinto (E)

Department of Surgery, National Defense Medical College, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.

Satsuki Mochizuki (S)

Department of Surgery, National Defense Medical College, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.

Koichi Okamoto (K)

Department of Surgery, National Defense Medical College, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.

Masato Yamadera (M)

Department of Surgery, National Defense Medical College, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.

Keisuke Yonemura (K)

Department of Surgery, National Defense Medical College, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.

Hideki Ueno (H)

Department of Surgery, National Defense Medical College, 3-2, Namiki, Tokorozawa, Saitama, 359-8513, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH